593
Participants
Start Date
November 18, 2005
Primary Completion Date
September 26, 2006
Study Completion Date
March 21, 2007
Iloperidone
Ziprasidone
Placebo
Vanda Investigational Site, Brooklyn
Vanda Investigational Site, Philadelphia
Vanda Investigational Site, Rockville
Vanda Investigational Site, Richmond
Vanda Investigational Site, Atlanta
Vanda Investigational Site, Augusta
Vanda Investigational Site, Maitland
Vanda Investigational Site, Fort Lauderdale
Vanda Investigational Site, Bradenton
Vanda Investigational Site, Cincinnati
Vanda Investigational Site, Hoffman Estates
Vanda Investigational Site, St Louis
Vanda Investigational Site, Saint Charles
Vanda Investigational Site, Lake Charles
Vanda Investigational Site, Little Rock
Vanda Investigational Site, Irving
Vanda Investigational Site, Houston
Vanda Investigational Site, Austin
Vanda Investigational Site, Los Angeles
Vanda Investigational Site, Pico Rivera
Vanda Investigational Site, Cerritos
Vanda Investigational Site, Paramount
Vanda Investigational Site, Glendale
Vanda Investigational Site, Upland
Vanda Investigational Site, National City
Vanda Investigational Site, Oceanside
Vanda Investigational Site, San Diego
Vanda Investigational Site, San Diego
Vanda Investigational Site, San Diego
Vanda Investigational Site, Santa Ana
Vanda Investigational Site, Anaheim
Vanda Investigational Site, Garden Grove
Vanda Investigational Site, Lucknow
Vanda Investigational Site, Jaipur
Vanda Investigational Site, Ahmedabad
Vanda Investigational Site, Pune
Vanda Investigational Site, Aurangabad
Vanda Investigational Site, Tirupati
Vanda Investigational Site, Chinawaltair
Vanda Investigational Site, Manipal
Vanda Investgational Site, Chennai
Vanda Investigational Site, Clementon
Lead Sponsor
Vanda Pharmaceuticals
INDUSTRY